Whitener Capital Management, Inc. Biogen Inc. Transaction History

Whitener Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $125,434 - $173,319	-570 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $21,929 - $24,172	-100 Reduced 14.93%	570 $133,000
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $4,334 - $6,779	-20 Reduced 2.9%	670 $158,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $13,925 - $17,637	50 Added 7.81%	690 $207,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $187,846 - $245,651	640 New	640 $226,000
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $169,963 - $202,560	-660 Closed	0 $0
Q4 2017 Apr 23, 2018	BUY	$307.64 - $344.58 $203,042 - $227,422	660	660 $210,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.